For over twenty years, CHAD Therapeutics, Inc. has been in the business of developing, producing and marketing respiratory care devices designed to improve the efficiency of oxygen delivery systems for home health care and hospital treatment of patients suffering from pulmonary diseases, such as COPD. We are the true innovators in home oxygen therapy and take great pride in being the leader in oxygen conservation. 

For information on CHAD Therapeutics, Inc. and the TOTAL O2^® product line, please go to www.ctuholdingsusa.com.